Last Updated : December 12, 2024
Details
| Call for patient/clinician input open | 28-Feb-23 |
|---|---|
| Call for patient/clinician input closed | 24-Apr-23 |
| Clarification: - Patient input submission received from the Canadian Skin Patient Alliance (CSPA) & Eczéma Québec and Eczema Society of Canada | |
| Submission received | 29-Mar-23 |
| Submission accepted | 13-Apr-23 |
| Review initiated | 14-Apr-23 |
| Draft CADTH review report(s) provided to sponsor for comment | 06-Jul-23 |
| Deadline for sponsors comments | 17-Jul-23 |
| CADTH review report(s) and responses to comments provided to sponsor | 11-Aug-23 |
| Expert committee meeting (initial) | 23-Aug-23 |
| Draft recommendation issued to sponsor | 06-Sep-23 |
| Draft recommendation posted for stakeholder feedback | 14-Sep-23 |
| End of feedback period | 28-Sep-23 |
| Final recommendation issued to sponsor and drug plans | 13-Oct-23 |
| Final recommendation posted | 31-Oct-23 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 27-Oct-23 |
| CADTH review report(s) posted | 12-Dec-23 |